US rheumatologists' beliefs and knowledge about biosimilars: a survey.

Gibofsky, Allan; McCabe, Dorothy

Gibofsky, Allan; McCabe, Dorothy.

Affiliation

Gibofsky A; Division of Rheumatology, Hospital for Special Surgery and Weill Cornell Medicine, New York, NY, USA.
McCabe D; Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA.

Rheumatology (Oxford) ; 60(2): 896-901, 2021 02 01.

Article in En | MEDLINE | ID: mdl-33146388

Subject(s)

Attitude of Health Personnel; Biosimilar Pharmaceuticals/pharmacology; Drug Substitution/methods; Rheumatic Diseases/drug therapy; Rheumatologists; Rituximab/pharmacology; Tumor Necrosis Factor Inhibitors/pharmacology; Antirheumatic Agents/pharmacology; Culture; Drug Approval/methods; Humans; Needs Assessment; Rheumatologists/psychology; Rheumatologists/statistics & numerical data; Social Perception; United States

Key words

United States; biosimilars; education; rheumatologists; survey

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Attitude of Health Personnel / Rheumatic Diseases / Drug Substitution / Biosimilar Pharmaceuticals / Rituximab / Rheumatologists / Tumor Necrosis Factor Inhibitors Type of study: Prognostic_studies Limits: Humans Country/Region as subject: America do norte Language: En Journal: Rheumatology (Oxford) Journal subject: REUMATOLOGIA Year: 2021 Document type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google